LOS ANGELES--(BUSINESS WIRE)--ImmunoCellular Therapeutics, Ltd. (OTCBB:IMUC) (IMUC), a biotechnology company, today announced that Manish Singh, Ph.D., president and chief executive officer, will present next week at the BIO Business Forum during the 2008 BIO International Convention to be held in San Diego, California from June 17-20. Dr. Singh will present at 10:45 am PDT on Thursday, June 19th, and will provide the audience with an overview of IMUC’s monoclonal antibody platform and preclinical-stage programs targeting multiple cancers. The lead compound, ICT-109, is a preclinical monoclonal antibody targeting small cell lung cancer and pancreatic cancer. The company is also developing a diagnostic test to potentially screen patients with these tumor markers who are most likely to benefit from this therapy.
